Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
- Previous Close
25.45 - Open
25.73 - Bid 25.15 x 73100
- Ask 25.75 x 19200
- Day's Range
24.95 - 25.78 - 52 Week Range
18.58 - 26.08 - Volume
233,514 - Avg. Volume
297,570 - Market Cap (intraday)
14.682B - Beta (5Y Monthly) 0.41
- PE Ratio (TTM)
61.51 - EPS (TTM)
0.41 - Earnings Date --
- Forward Dividend & Yield 0.33 (1.32%)
- Ex-Dividend Date Dec 5, 2023
- 1y Target Est
22.09
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
www.fphcare.comRecent News: FPH.AX
Performance Overview: FPH.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FPH.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FPH.AX
Valuation Measures
Market Cap
14.57B
Enterprise Value
14.80B
Trailing P/E
61.49
Forward P/E
47.17
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.41
Price/Book (mrq)
9.17
Enterprise Value/Revenue
8.66
Enterprise Value/EBITDA
31.40
Financial Highlights
Profitability and Income Statement
Profit Margin
15.45%
Return on Assets (ttm)
9.98%
Return on Equity (ttm)
16.20%
Revenue (ttm)
1.69B
Net Income Avi to Common (ttm)
261.7M
Diluted EPS (ttm)
0.41
Balance Sheet and Cash Flow
Total Cash (mrq)
70.5M
Total Debt/Equity (mrq)
18.46%
Levered Free Cash Flow (ttm)
-87.96M
Research Analysis: FPH.AX
Company Insights: FPH.AX
FPH.AX does not have Company Insights